A systematic review and meta-analysis of community and primary-care-based hepatitis C testing and treatment services that employ direct acting antiviral drug treatments

Abstract Background Direct Acting Antiviral (DAAs) drugs have a much lower burden of treatment and monitoring requirements than regimens containing interferon and ribavirin, and a much higher efficacy in treating hepatitis C (HCV). These characteristics mean that initiating treatment and obtaining a...

Full description

Bibliographic Details
Main Authors: Andrew Radley, Emma Robinson, Esther J. Aspinall, Kathryn Angus, Lex Tan, John F. Dillon
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Health Services Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12913-019-4635-7